康泰生物: 2025年第一季度可转换公司债券转股情况公告

Group 1 - The core point of the announcement is the update on the convertible bonds issued by Shenzhen Kangtai Biological Products Co., Ltd., including the current conversion price and the changes in the company's total share capital due to bond conversions [1][2][4] - The company issued 20 million convertible bonds with a total fundraising amount of RMB 2 billion, with a face value of RMB 100 per bond, approved by the China Securities Regulatory Commission [1][2] - The convertible bonds, named "Kangtai Zhuan 2," were listed on the Shenzhen Stock Exchange on August 5, 2021, and the current conversion price is RMB 15.82 per share [2][4] Group 2 - As of March 31, 2025, the total number of convertible bonds remaining is 19,990,146, with a remaining convertible bond amount of RMB 1,999,014,600 [2] - The company's share capital structure shows a decrease in restricted shares from 235,537,028 to 231,096,718, while unrestricted shares increased from 881,390,709 to 885,831,169, resulting in a total share capital of 1,116,927,887 shares [2][4] - The changes in share capital are attributed to the recalculation of executive lock-up shares and the automatic lock-up of shares held by newly appointed directors and executives [2][4]